Eli Lilly and Company - FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression

Links shared publicly online about this topic.

  • 2,169
    total visits

Eli Lilly and Company - FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression

newsroom.lilly.com

Eli Lilly and Company - FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression

View full resource at newsroom.lilly.com

Tags: Depression, Drug, FDA, Eli Lilly and Company

  • Share

Most Recently Shared on March 23, 2009 at 12:54 pm By:

eyeonfda eyeonfda

FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression - http://is.gd/ox9b

3 years ago...

Advertisement